Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome

Inflammatory breast cancer (IBC) represents a rare but aggressive and lethal form of locally advanced breast cancer (LABC) and frequently with HER-2 neu overexpressed or amplified. We retrospectively identified 16 newly diagnosed HER-2/neu-positive IBC patients who were treated with preoperative tra...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Dawood, Shaheenah, Gong, Yun, Broglio, Kristine, Buchholz, Thomas A., Woodward, Wendy, Lucci, Anthony, Valero, Vicente, Gonzalez-Angulo, Ana M., Hortobagyi, Gabriel N., Cristofanilli, Massimo
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2010
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3097300/
https://ncbi.nlm.nih.gov/pubmed/20626396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-4741.2010.00953.x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk